Franciscus Raphelengius

Recent publications · Crossref

5 total works indexed

1. Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

   · 2017 · cited 503x

2. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

   · 2022 · cited 405x

3. An overview of ecological status, vulnerability and future perspectives of European large shallow, semi-enclosed coastal systems, lagoons and transitional waters

   · 2014 · cited 363x

4. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   · 2022 · cited 285x

5. Temporal Stability in Chronic Wound Microbiota Is Associated With Poor Healing

   · 2017 · cited 277x

via Crossref · CC0